Xilio Therapeutics (XLO) EBT (QoQ) (2020 - 2026)
Xilio Therapeutics (XLO) EBT (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,290.43 Bn | 66,290.15 Bn | - |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 467.97 Bn | 463.18 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.73 Bn | 115.48 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.82 Bn | 62.82 Bn | - |
| 8 | Argenx Se | 56.00 Bn | 50.82 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.51 Bn | 34.50 Bn | 959.66 Mn |
| 10 | Xilio Therapeutics | 145.98 Mn | -4.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.12% |
| Dec 31, 2025 | -494.04% |
| Sep 30, 2025 | 86.14% |
| Jun 30, 2025 | -3.56% |
| Mar 31, 2025 | 0.01% |
| Dec 31, 2024 | 6.39% |
| Sep 30, 2024 | 0.12% |
| Jun 30, 2024 | 16.41% |
| Mar 31, 2024 | 7.35% |
| Dec 31, 2023 | -10.39% |
| Sep 30, 2023 | 13.81% |
| Jun 30, 2023 | 14.92% |
| Mar 31, 2023 | 2.81% |
| Dec 31, 2022 | -19.56% |
| Sep 30, 2022 | 17.72% |
| Jun 30, 2022 | -15.87% |
| Mar 31, 2022 | -8.99% |
| Dec 31, 2021 | 38.10% |
| Sep 30, 2021 | -37.43% |
| Jun 30, 2021 | -38.20% |